ClinicalTrials.Veeva

Menu

Blood Donor Recruitment During Epidemic of COVID-19

G

Guangzhou Blood Center

Status

Completed

Conditions

Blood Donation

Treatments

Other: Questionnaire with precaution information
Other: Experimental: Questionnaire without precaution information

Study type

Interventional

Funder types

Other

Identifiers

NCT04306055
Blood donor recruitment

Details and patient eligibility

About

In December 2019, an unknown pneumonia rapidly spread in Wuhan, China, a new coronavirus, 2019 novel coronavirus (2019-nCoV), aroused the attention of the entire world. On January 31, 2020, World Health Organization (WHO) announced the outbreak of Coronavirus Disease 2019 (COVID-19) in China as a Public Health Emergency of International Concern. The number of volunteer non-remunerated blood donors decreased because of quarantine, caring for relatives, and fear of exposure to COVID-19. Due to the blood shortage, patient blood management and cessation of elective surgery are contributing to decreased demand, but sepsis may increase requirements and significant reductions will not be possible in areas such as trauma, cancer patients, hereditary haemolytic anaemias and childbirth. Therefore, recruiting enough blood donors during the epidemic is vital for public health in China, and also worldwide. In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not. The questionnaires were randomly sent to ever blood donors, and the same number of ever blood donors are coded as control.

Full description

In order to assess the effects of a questionnaire on blood donor recruitment, the investigators designed two kinds of self-administered, standardized and structured questionnaires. In addition of the basic socio-demographic characteristics, one questionnaire includes the information of precautions of blood donation during epidemic, and the other dose not.

Information of precautions of blood donation during epidemic included taking donor's temperature and enhancing hand disinfection before donation etc.

The questionnaires were randomly sent to ever blood donors, and at the same day, equal number of ever blood donors as the ones who filled the questionnaire are coded as control.

Enrollment

19,491 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Blood donors whose last donation were between 1 Feb to 31 March, 2019.

Exclusion criteria

  • Blood donors whose blood test results were positive. Blood donors who were aged above 60. Blood donors whose cell phone number was obviously invalid.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

19,491 participants in 3 patient groups

Questionnaire with precaution information
Experimental group
Description:
Questionnaire in this group includes information about precaution of blood donation during epidemic of COVID-19.
Treatment:
Other: Questionnaire with precaution information
Questionnaire without precaution information
Experimental group
Description:
Questionnaire in this group dose not include information about precaution of blood donation during epidemic of COVID-19.
Treatment:
Other: Experimental: Questionnaire without precaution information
No questionnaire group
No Intervention group
Description:
Ever donors in this group would not receive the questionnaire.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems